Leukemia News

A Paradigm Shift In Treating Adult AML? - The ASCO Post

A Paradigm Shift In Treating Adult AML? The ASCO Post

Blood Transfusions Help 4-Year-Old Girl Battle Leukemia - American Red Cross

Blood Transfusions Help 4-Year-Old Girl Battle Leukemia American Red Cross

Trial in Rare Leukemia Shows “Unprecedented Result” With Blinatumomab - CancerNetwork

Trial in Rare Leukemia Shows “Unprecedented Result” With Blinatumomab CancerNetwork

How seemingly minor skin conditions can lead to a leukemia diagnosis - Florida Today

How seemingly minor skin conditions can lead to a leukemia diagnosis Florida Today

Mom Issues Desperate Plea for Stem Cell Donor to Save the Life of Her 17-Year-Old Son with Leukemia (Exclusive) - People.com

Mom Issues Desperate Plea for Stem Cell Donor to Save the Life of Her 17-Year-Old Son with Leukemia (Exclusive) People.com

Characteristics and outcome determinants in children, adolescents and young adults who failed tisagenlecleucel for B-cell acute lymphoblastic leukemia - Nature

Characteristics and outcome determinants in children, adolescents and young adults who failed tisagenlecleucel for B-cell acute lymphoblastic leukemia Nature

WVU Cancer Institute first in the world to treat ultra-rare leukemia using novel subcutaneous immunotherapy - Parsons Advocate

WVU Cancer Institute first in the world to treat ultra-rare leukemia using novel subcutaneous immunotherapy Parsons Advocate

Pesticide Exposure Again Linked to Childhood Acute Lymphoblastic Leukemia, as Rates Rise - Beyond Pesticides

Pesticide Exposure Again Linked to Childhood Acute Lymphoblastic Leukemia, as Rates Rise Beyond Pesticides

Real-World Analysis Reveals Favorable Outcomes With Liso-Cel in Chronic Lymphocytic Leukemia - OncLive

Real-World Analysis Reveals Favorable Outcomes With Liso-Cel in Chronic Lymphocytic Leukemia OncLive

New Date: Swing For a Cause Golf Fundraiser to Support Blood Cancer United and Local Child Battling Leukemia on March 2 - TAPinto

New Date: Swing For a Cause Golf Fundraiser to Support Blood Cancer United and Local Child Battling Leukemia on March 2 TAPinto

FDA Approval of CLL Combo Marks New Era for Leukemia Care - AJMC

FDA Approval of CLL Combo Marks New Era for Leukemia Care AJMC

Acute Myeloid Leukemia: Patricia's Story - BMT infonet.org

Acute Myeloid Leukemia: Patricia's Story BMT infonet.org

Medical milestone: Cell therapy comes to solid tumors - 6abc Philadelphia

Medical milestone: Cell therapy comes to solid tumors 6abc Philadelphia

Which Children Are at Risk for Neurotoxicity After CAR T-Cell Therapy? | Newswise - Newswise

Which Children Are at Risk for Neurotoxicity After CAR T-Cell Therapy? | Newswise Newswise

Blood drive honors Fort Wayne man’s battle with Leukemia - WPTA | 21Alive | Fort Wayne, IN

Blood drive honors Fort Wayne man’s battle with Leukemia WPTA | 21Alive | Fort Wayne, IN

First-in-World Leukemia Trial Aims to Leave No Patients Behind - CancerNetwork

First-in-World Leukemia Trial Aims to Leave No Patients Behind CancerNetwork

Marrow leptin-LEPR signaling rewires mitochondrial oxidative metabolism to confer chemoresistance in acute myeloid leukemia - Nature

Marrow leptin-LEPR signaling rewires mitochondrial oxidative metabolism to confer chemoresistance in acute myeloid leukemia Nature

First-in-World Trial Explores Subcutaneous Blinatumomab in Rare Leukemia - CancerNetwork

First-in-World Trial Explores Subcutaneous Blinatumomab in Rare Leukemia CancerNetwork

Development of a prognostic scoring system for chronic myeloid leukemia in blast phase - Nature

Development of a prognostic scoring system for chronic myeloid leukemia in blast phase Nature

FDA Approves AstraZeneca Oral Treatment for Lymphocytic Leukemia and Lymphoma - Contract Pharma

FDA Approves AstraZeneca Oral Treatment for Lymphocytic Leukemia and Lymphoma Contract Pharma

Yale Study Identifies a New Class of Drug Targets for Aggressive Leukemia - Yale School of Medicine

Yale Study Identifies a New Class of Drug Targets for Aggressive Leukemia Yale School of Medicine

Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia | New England Journal of Medicine - The New England Journal of Medicine

Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia | New England Journal of Medicine The New England Journal of Medicine

Venetoclax Plus Rituximab for Relapse/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Network Meta-analysis of Treatments Available in Brazil - springermedicine.com

Venetoclax Plus Rituximab for Relapse/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Network Meta-analysis of Treatments Available in Brazil springermedicine.com

Blackstone Life Sciences Announces a Co-funding Agreement for Acute Myeloid Leukemia - WebWire

Blackstone Life Sciences Announces a Co-funding Agreement for Acute Myeloid Leukemia WebWire

Blackstone Life Sciences Announces A Co-Funding Agreement For Acute Myeloid Leukemia - TradingView

Blackstone Life Sciences Announces A Co-Funding Agreement For Acute Myeloid Leukemia TradingView

Brownsville native writes book about surviving leukemia - MyRGV.com

Brownsville native writes book about surviving leukemia MyRGV.com

Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology) - Nature

Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology) Nature